A Phase I-II Study of Novel Oncolytic Virus VG161 Via Intravesical Instillation for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
Clinical trial NCT07505615 · COMPLETED
Trial details
- NCT number
- NCT07505615
- Sponsor
- Ding-Wei Ye
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2023-04-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.